Benitec Biopharma (BNTC) Cash from Operations (2019 - 2025)
Benitec Biopharma (BNTC) reported Cash from Operations of 3700000.0 for Q4 2025, up 51.97% on a YoY basis from 2434742.87 in Q4 2024, and down 8.82% sequentially from 3400000.0 in Q3 2025.
Benitec Biopharma (BNTC) Cash from Operations (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 7 years of Cash from Operations data on file, last reported at 3700000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Operations rose 51.97% year-over-year to 3700000.0; the trailing twelve-month figure through Dec 2025 stood at 18411000.0 (up 15.5% YoY), and the FY2025 full-year result was 23600000.0, down 21.65% from the prior year.
- Cash from Operations declined to 3700000.0 in Q4 2025, from 3400000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 1989000.0 in Q1 2021 to a low of 8225000.0 in Q2 2025.
- A 5-year average of 4557300.0 and a median of 4191500.0 in 2021 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations tumbled 158.65% in 2021 and soared 51.97% in 2025, its largest moves.
- Tracing BNTC's Cash from Operations over 5 years: stood at 3300000.0 in 2021, then tumbled by 77.42% to 5855000.0 in 2022, then advanced by 9.48% to 5300000.0 in 2023, then sank by 45.34% to 7703000.0 in 2024, then soared by 51.97% to 3700000.0 in 2025.
- Business Quant data shows BNTC's Cash from Operations at 3700000.0 in Q4 2025, 3400000.0 in Q3 2025, and 8225000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - | -3.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.70 Mn |
| Dec 31, 2025 | -3.70 Mn |
| Sep 30, 2025 | -3.40 Mn |
| Sep 30, 2025 | -3.40 Mn |
| Jun 30, 2025 | -8.23 Mn |
| Jun 30, 2025 | -8.23 Mn |
| Mar 31, 2025 | -3.09 Mn |
| Mar 31, 2025 | -3.09 Mn |
| Dec 31, 2024 | -7.70 Mn |
| Dec 31, 2024 | -7.70 Mn |
| Sep 30, 2024 | -4.59 Mn |
| Sep 30, 2024 | -4.59 Mn |
| Jun 30, 2024 | -3.29 Mn |
| Jun 30, 2024 | -3.29 Mn |
| Mar 31, 2024 | -6.21 Mn |
| Mar 31, 2024 | -6.21 Mn |
| Dec 31, 2023 | -5.30 Mn |
| Dec 31, 2023 | -5.30 Mn |
| Sep 30, 2023 | -4.60 Mn |
| Sep 30, 2023 | -4.60 Mn |